Form 4: Alexander & Baldwin Executive Vice President Sells Shares Under 10b5-1 Trading Plan

Sentiment:

Form 4 Filing


Alexander & Baldwin's Executive Vice President, Meredith J. Ching, sold 700 shares of common stock at a weighted average price of $19.3740, as part of a pre-arranged 10b5-1 trading plan.

Summary

  • Meredith J. Ching, Executive Vice President of Alexander & Baldwin, Inc., sold 700 shares of common stock on December 10, 2024.
  • The sale was executed under a Rule 10b5-1 trading plan.
  • The weighted average price of the shares sold was $19.3740.
  • The shares were sold in multiple transactions with prices ranging from $19.325 to $19.60.
  • The total value of the shares sold was $14,916.70.

Sentiment

Score: 5

Explanation: The document describes a routine executive stock sale under a pre-arranged plan, which is neither positive nor negative for the company's overall outlook.

Industry Context

Executive stock sales are a common occurrence and are often part of pre-arranged trading plans to avoid accusations of insider trading. This transaction is not unusual for a company of this size.

Comparison to Industry Standards

  • Executive stock sales are a normal part of corporate activity, and the use of 10b5-1 trading plans is a standard practice to ensure compliance with insider trading regulations.
  • The volume of shares sold is relatively small compared to the overall market capitalization of Alexander & Baldwin, and the price range is within normal market fluctuations.

Stakeholder Impact

  • The stock sale by an executive may have a minor impact on shareholder sentiment, but the use of a 10b5-1 plan suggests it was not based on any new material information.

Key Dates

DateDescription
2024-12-10Date of the stock sale by Meredith J. Ching.

Keywords

Alexander & Baldwin, stock sale, 10b5-1 trading plan, executive transaction, Meredith J. Ching, common stock

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.